Kolexia
Andre Pierre Dermatologie
Andre Pierre
Dermatologie
Cabinet libéral
Paris, France
17 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome épidermoïde Carcinomes Syndrome de Nicolau Tumeurs de la tête et du cou {{person.topmesh6.name}} {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Boisnic Sylvie
Boisnic Sylvie
Hôpital Pitie Salpetriere, Paris, France
Deutsch Jean-Jacques
Deutsch Jean-Jacques
Cabinet libéral, Paris, France
Boyer-Chammard Agnes
Boyer-Chammard Agnes
Innate Pharma, Marseille, France
Fayette Jérôme
Fayette Jérôme
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
Galderma
3 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Predicting the evolution of clinical skin aging in a multi-ethnic population: Developing causal Bayesian networks using dermatological expertise.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)   14 février 2024
A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study.
The Journal of dermatological treatment   14 août 2023
199TiP A first-in-human phase I study of IPH5301, an anti-CD73 monoclonal antibody, alone or in combination with chemotherapy and trastuzumab, in patients with advanced solid tumors (CHANCES)
Abstract Book of the ESMO Immuno-Oncology Congress 2022 7-9 December 2022   01 décembre 2022
HEBE2: Evaluation of Anti-aging Performance and Tolerance of a Hyaluronic Acid-based Filler NCTF135HA® Medical Device, on Filling the Superficial Wrinkles and on Skin Quality: HEBE2 Study
Essai Clinique (Laboratoires Fillmed)   07 novembre 2022
123MO Monalizumab, cetuximab and durvalumab in first-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): A phase II trial
ESMO Immuno-Oncology Congress 2021 08-11 December 2021   01 décembre 2021
Objective 18-month Comparison of the Tolerability of 2 Dermal Fillers Formulated with Tri-Hyal Technology.
Plastic and reconstructive surgery. Global open   09 décembre 2020
81P Monalizumab in combination with cetuximab post platinum and anti-PD-(L)1 in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Updated results from a phase II trial
Abstract Book of the ESMO Immuno-Oncology Virtual Congress 2020 9-12 December 2020   01 décembre 2020
Monalizumab in combination with cetuximab in patients (pts) with recurrent or metastatic (R/M) head and neck cancer (SCCHN) previously treated or not with PD-(L)1 inhibitors (IO): 1-year survival data
Abstract Book of the 44th ESMO Congress (ESMO 2019) 27 September – 1 October 2019, Barcelona, Spain   01 octobre 2019
Prospective, Split-Face, Randomized, Long-Term Blinded Objective Comparison of the Performance and Tolerability of Two New Hyaluronic Acid Fillers.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]   30 avril 2018
Nicolau syndrome due to hyaluronic acid injections.
Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology   22 avril 2016